Van Leeuwen & Company, LLC Bristol Myers Squibb CO Transaction History

Van Leeuwen & Company, LLC

$196 Million
Q1 2024

A detailed history of Van Leeuwen & Company, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Van Leeuwen & Company, LLC holds 52,025 shares of BMY stock, worth $3.07 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

52,025

Previous 61,933 16.0%

Holding current value

$3.07 Million

Previous $3.18 Million 11.21%

% of portfolio

1.44%

Previous 1.86%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $475,385 - $538,995	-9,908 Reduced 16.0%	52,025 $2.82 Million
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $876,857 - $1.05 Million	-18,087 Reduced 22.6%	61,933 $3.18 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $1,157 - $1,294	20 Added 0.03%	80,020 $4.64 Million
Q2 2023 Feb 06, 2024	SELL	$63.71 - $70.74 $1,274 - $1,414	-20 Reduced 0.02%	80,000 $5.12 Million
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $164,053 - $182,155	-2,575 Reduced 3.12%	80,000 $5.15 Million
Q1 2023 Feb 06, 2024	SELL	$65.71 - $74.53 $57,167 - $64,841	-870 Reduced 1.04%	82,575 $5.72 Million
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $57,167 - $64,841	-870 Reduced 1.04%	82,575 $5.72 Million
Q4 2022 Feb 06, 2024	BUY	$68.48 - $81.09 $234,544 - $277,733	3,425 Added 4.28%	83,445 $6 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $39,512 - $46,788	-577 Reduced 0.69%	83,445 $6 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $42 - $25,280	-329 Reduced 0.39%	84,022 $5.97 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $5.89 Million - $6.49 Million	81,136 Added 2523.67%	84,351 $6.5 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $5.49 Million - $6.59 Million	-89,366 Reduced 96.53%	3,215 $235,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $119,326 - $139,107	-2,225 Reduced 2.35%	92,581 $5.77 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $5,325 - $6,237	90 Added 0.1%	94,806 $5.61 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $2.78 Million - $3.02 Million	44,838 Added 89.9%	94,716 $6.3 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $613,041 - $689,490	10,331 Added 26.12%	49,878 $3.15 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $2.97 Million - $3.37 Million	-51,510 Reduced 56.57%	39,547 $2.45 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $2.98 Million - $3.3 Million	51,823 Added 132.09%	91,057 $5.49 Million
Q2 2020 Aug 03, 2020	BUY	$54.82 - $64.09 $154,702 - $180,861	2,822 Added 7.75%	39,234 $2.31 Million
Q1 2020 Apr 23, 2020	BUY	$46.4 - $67.43 $12,249 - $17,801	264 Added 0.73%	36,412 $2.03 Million
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $825,793 - $1.08 Million	16,781 Added 86.65%	36,148 $2.32 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $1.43 Million - $1.7 Million	-33,477 Reduced 63.35%	19,367 $982,000
Q2 2019 Jul 31, 2019	BUY	$44.62 - $49.34 $2.36 Million - $2.61 Million	52,844 New	52,844 $2.4 Million

Others Institutions Holding BMY

# of Institutions

2,602

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Leeuwen & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Leeuwen & Company, LLC with notifications on news.

Account

Van Leeuwen & Company, LLC Bristol Myers Squibb CO Transaction History